Mednet Logo
HomePrimary CareQuestion

How do you approach pharmacologic management of OCD in patients with comorbid bipolar disorder, particularly when considering SSRIs or clomipramine?

5
4 Answers
Mednet Member
Mednet Member
Psychiatry · Massachusetts General Hospital (MGH) and Harvard Medical School (HMS)

This is a great question! Depending on the study you read, anywhere from 10% to 25% of patients with bipolar disorder have comorbid OCD.

The challenge, as you might imagine, is that treatment with SRIs in the absence of a mood stabilizer may run the risk of inducing a manic episode. A larger debate...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Psychiatry · Private Practice

First, I always reevaluate the diagnosis; did I miss the frenetic hyperactive thoughts for OCD? Am I seeing a patient with ADHD core symptomatology who has learned to organize by anxiety energy and OC patterns to stay organized and functional? Otherwise, the above responses in clear cases are great ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Psychiatry · University of Miami Miller School of Medicine/ Jackson Memorial Hospital - Jackson Health System

Not too complex. The chances of the switch are minimal, particularly if you have a reasonable level of lithium. The only consideration is that you'll need about twice the approved doses, and you will have to wait 8-12 weeks. Also, if you do not have ERP CBT, do not expect miracles. As to memantine o...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Psychiatry · Private Practice

I have encountered one young patient who states he was entirely cured of relatively severe OCD symptoms by reading the book "Brain Lock" by Jeffrey M. Schwartz. I believe Dr. Schwartz must not be highly regarded by the OCD Academic mainstream, as there is not a single reference to Jeffrey Schwartz o...

Register or Sign In to see full answer

How do you approach pharmacologic management of OCD in patients with comorbid bipolar disorder, particularly when considering SSRIs or clomipramine? | Mednet